AbbVie enters $3.8bn deal with Genmab
The two companies will collaborate on Genmab’s lead bispecific antibody treatment and develop further candidates.
Archives for June 11, 2020
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs